Print

Håkan Åström leaves the Board of Active Biotech

2003-01-15

Since Active Biotech acquired all the project rights from Pharmacia, Pharmacia's ownership in Active Biotech, amounting to 24,1 percent of capital, has changed to be of pure financial nature.
Lund 15 January, 2003
Active Biotech AB (publ)
Sven Andréasson
President & CEO
Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/inflammatory diseases and cancer. Most advanced projects include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases (SAIK), as well as a novel concept for use in cancer immunotherapy (TTS).
Active Biotech AB
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 20 50
e-mail info@activebiotech.com

pdf



Back